ArticleJournal of molecular evolution2025
Co-evolution of alpha-helical transmembrane protein residues: large-scale variant profiling and complete mutational landscape of 2277 known PDB entries representing 504 unique human protein sequences.
Article in Journal of molecular evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- In silico directed evolution of humanized peptide transporters via computational epistatic rescue.Molecular diversity · 2026Article
- Integrative Structural Bioinformatics and Molecular Dynamics Analyses of Synaptic Vesicle Proteins and Their Water-Soluble QTY-Variants Reveal Membrane Constraints and Evolutionary Coupling of T ⇔ V.Journal of molecular evolution · 2026Article
- The KW18 peptide acts as a dual antimicrobial and immunomodulatory therapeutic candidate in the context of antimicrobial resistance.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Membrane proteins play fundamental roles in cellular function, yet the evolutionary dynamics of their amino acid composition remain poorly understood. Our current study investigates the substitutional landscape and evolutionary patterns of hydrophilic and hydrophobic residues in membrane α-helical proteins, addressing a significant gap in our knowledge of protein evolution. We analyzed 2277 high-resolution protein structures from the RCSB Protein Data Bank corresponding to 458 unique PDB structures, 504 UniProt transmembrane entries and their AlphaMissense predicted mutational libraries including more than 5.8 million amino acid substitutions, focusing on known transmembrane α-helical proteins in Homo sapiens. Our analysis showed that the pathological outcome of the substitutions is diverse, as nonpolar to polar changes showed higher pathological scores in general. Notably, F <=> Y substitutions showed significantly lower pathological scores. Our further analysis revealed a significant asymmetry in the evolutionary frequencies of polar and nonpolar amino acids. We identified key residue pairs driving this asymmetry, with F <=> Y, A <=> T, V <=> T and A <=> S co-evolution diverging from the expected negative correlations (Spearman's rho > 0.20, p < 0.001). The V <=> T substitution via an alanine intermediate and the G <=> N substitution via a serine intermediate lower their statistical barrier, which would otherwise require two sequential base changes. We propose two evolutionary game theory (EGT) based models to explain their diversification, with partial correlation analysis on residue frequencies in homolog sequences. These mathematical insights suggest a previously unrecognized evolutionary pressure, potentially linked to functional diversification, which could be targeted to combat drug resistance. Our results offer insights into membrane protein evolution and may inform improved methods for protein structure prediction and design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.